Comparison of two medications given under ultrasound guidance in pain and functional functional improvement of patients with jaw pain due to osteoarthritis

Comparison of ultrasound guided intra-articular injection of platelet rich plasma and triamcinolone acetonide in the reduction of pain and functional improvement in primary temporomandibular joint osteoarthritis: A randomized controlled trial - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058975

Enrollment

Registered

2023-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M19- Other and unspecified osteoarthritis

Interventions

Intervention1: I/A injection of platelet rich plasma(1ml) in temporomandibular joint given once: I/A injection of platelet rich plasma(1ml) under ultrasound guidance given once on day 0(first visit af

Eligibility

Inclusion criteria

Inclusion criteria: symptomatic primary temporomandibular joint osteoarthritis (TMJ OA) unilateral TMJ OA CT confirmed cases of TMJ OA patients willing to be part of study and follow up

Exclusion criteria

Exclusion criteria: patients with previous trauma or dental intervention H/O inflammatory arthritis uncontrolled systemic illness bleeding disorder allergic to local anaesthetics thrombocytopenia

Design outcomes

Primary

Measure	Time frame
1. pain through VAS Timepoint: 1. 1 week 2. 4 week 3. 12 week 4. 24 week Pain expected to improve at 1 week with prolong effect till 24 week of follow up	—

Secondary

Measure	Time frame
Pain and function of temporomandibular joint assessed through VAS and MFIQTimepoint: 1. 1 week 2. 4 week 3. 12 week 4. 24 week VAS improvement expected from 1 week MFIQ score improvement expected on later follow up till 24 weeks, at 24 weeks MFIQ score improvement is questionable	—

Countries

India

Contacts

Public ContactShruti Pandey

Regional Institute of Medical Sciences

drnilalong@gmail.com08981795747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026